UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) ~~December~~: November 1614, ~~2007~~2008

MEDICAL SOLUTIONS MANAGEMENT INC.

(Exact name of registrant as specified in its charter)

Nevada

0-27084

86-0214815

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

237 Cedar Hill Street

~~Marlboro~~Marlborough, MAMassachusetts 01752

(Address of principal executive offices) (Zip Code)

(508) 597-6300

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01. Entry into a Material Definitive Agreement.

~~Item~~On November 14, 22008, Medical Solutions Management Inc.03 ~~Creation~~(the “Registrant”) entered into the Third Amendment to Revolving Line of aCredit ~~Direct~~Agreement ~~Financial~~(“Line ~~Obligation~~of orCredit anAmendment”) ~~Obligation~~with ~~under~~Sovereign anBank ~~Off-Balance~~(“Sovereign”), ~~Sheet~~which amended ~~Arrangement~~the Registrant’s existing line of credit with Sovereign as follows: (i) extending the maturity date from one hundred twenty (120) days prior to expiry of the Letter of Credit (defined below) to December 14, 2008; and (ii) changing the interest rate on the principal balance, from time to time outstanding, from (a) a fluctuating rate per annum equal to, at the election of the Registrant, the sum of the then LIBOR rate plus a margin ranging from .75% to 1.25% or the then Prime rate less 200 basis points to (b) Sovereign Bank’s prime rate, as it may exist from time to time. As of November 14, 2008, the outstanding principal balance under the line of credit was $3,000,000.

OnPreviously, ~~December~~on March 16, 2007, the ~~Medical~~Custodial ~~Solutions~~Trust ~~Management~~Company ~~Inc.~~(“CTC”) issued an irrevocable letter of credit in favor of Sovereign (as amended, the “~~Company~~Letter of Credit”) ~~entered~~and ~~into~~the aRegistrant, ~~note~~CTC ~~purchase~~and ~~agreement with~~ Vicis Capital Master Fund (“Vicis”) entered into a Letter of Credit Reimbursement, Guarantee, Security and Pledge Agreement pursuant to which the Registrant ~~Company~~agreed ~~issued~~to areimburse ~~promissory~~CTC ~~note~~for inany ~~the~~payments ~~principal~~CTC ~~amount~~is required to make under the letter of ~~$1,000,000~~credit it issued in favor of Sovereign. Vicis ~~and~~guaranteed athe ~~warrant~~Registrant’s ~~for~~performance ~~2,500,000~~of ~~shares~~such ofobligations ~~the~~and ~~Company’s~~in ~~common~~connection ~~stock~~therewith deposited with CTC certain of its assets. ~~The~~As ~~Company~~of ~~received~~November 14, $12008,~~000,000~~ inthe ~~cash~~expiry ~~in consideration~~date ~~for~~of the ~~issuance~~Letter of ~~the~~Credit ~~promissory~~was ~~note~~March 15, 2009 and the ~~warrant~~Letter of Credit was for an aggregate amount of $3,060,000.

~~The~~A ~~maturity~~copy ~~date~~ of the ~~promissory~~Line ~~note is December 16, 2008. Interest accrues under the note at the rate~~ of ~~5% per~~Credit ~~annum.~~Amendment ~~The Company~~ is ~~not~~attached ~~permitted~~as toExhibit ~~prepay principal or interest under the promissory note~~10.1 ~~Under the note purchase agreement, Vicis has the option~~ to ~~convert~~this ~~the~~Current ~~promissory~~Report ~~note into equity or convertible debt securities sold by the Company in connection with a future financing~~ on ~~the~~Form 8-K ~~terms~~ and ~~conditions~~is ofincorporated ~~such financing, subject to a discount of 16.67% of the price per security offered~~ by ~~the~~reference ~~Company~~herein. ~~Upon such conversion,~~ ~~the Company shall have no obligations under the promissory note.~~

~~The~~Item ~~exercise price of the warrant is $0~~9.4001 ~~per~~Financial ~~share~~Statements ~~(subject to adjustment upon the occurrence of certain events)~~ and ~~will be exercisable for 5 years~~Exhibits. The Company and Vicis also entered into a Registration Rights Agreement with respect to the shares to be issued upon exercise of the warrant, whereby Vicis would be allowed to participate in any future registration of the Company’s shares of common stock, subject to the limitations in the agreement.

Item 9.01 Financial Statements and Exhibits

(d)

Exhibits

Exhibit		Description
10.1		~~Note~~Third ~~Purchase~~Amendment to Revolving Line of Credit Agreement dated ~~December~~as 16of November 14, ~~2007~~2008 by and between Medical Solutions Management Inc. and ~~Vicis~~Sovereign ~~Capital Master Fund~~Bank
10.2		Promissory Note dated December 16, 2007 issued in favor of Vicis Capital Master Fund
10.3		Series CS Warrant to Purchase Shares of Common Stock No. CS-13 dated December 16, 2007 issued in favor of Vicis Capital Master Fund
10.4		Registration Rights Agreement dated December 16, 2007 between Medical Solutions Management Inc. and Vicis Capital Master Fund

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: ~~December~~November 2019, ~~2007~~2008

MEDICAL SOLUTIONS MANAGEMENT INC. By: /s/ ~~Brian~~Lowell ~~Lesperance~~Fisher Name: ~~Brian~~Lowell ~~Lesperance~~Fisher Title: President and ~~Treasurer~~Interim Chief Executive Officer

EXHIBIT LIST

Exhibit		Description
10.1		~~Note~~Third ~~Purchase~~Amendment to Revolving Line of Credit Agreement dated ~~December~~as 16of November 14, ~~2007~~2008 by and between Medical Solutions Management Inc. and ~~Vicis~~Sovereign ~~Capital Master Fund~~Bank
10.2		Promissory Note issued December 16, 2007 in favor of Vicis Capital Master Fund
10.3		Series CS Warrant to Purchase Shares of Common Stock No. CS-13 dated December 16, 2007 issued in favor of Vicis Capital Master Fund
10.4		Registration Rights Agreement dated December 16, 2007 between Medical Solutions Management Inc. and Vicis Capital Master Fund

Filing Compare · MEDICAL SOLUTIONS MANAGEMENT INC.